WATERS CORP /DE/ (WAT) — Current Report

AI-Powered SEC Filing Analysis

← All WAT filings

Want the newest filings?

This analysis covers the filing from 2026-01-27. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Earlier Current Report filings

Filed: 2026-01-16
  • Waters Corporation has entered into a Reverse Morris Trust transaction with Becton, Dickinson and Company (BD) to acquire BD's Biosciences and Diagnostic Solutions business.
  • Waters has filed relevant materials with the SEC, including a registration statement on Form S-4 that includes a preliminary proxy statement/prospectus for its stockholders to vote on the merger.
  • Two lawsuits have been filed by purported Waters stockholders alleging that the proxy statement/prospectus omitted certain material information, prompting Waters to provide supplemental disclosures to address these claims.
Filed: 2026-01-12
  • Waters Corporation is presenting an investor presentation at the J.P. Morgan Healthcare Conference on January 12, 2026, which will provide high-level commentary on the company's business performance.
  • Waters Corporation has filed relevant materials with the SEC, including a registration statement on Form S-4 that includes a preliminary proxy statement/prospectus and a registration statement on Form 10 for its spinoff from Becton, Dickinson and Company.
  • Investors and security holders are urged to review the filed documents carefully, as they contain important information about the proposed transaction between Waters, Augusta SpinCo Corporation, and Becton, Dickinson and Company.

Other reports for WATERS CORP /DE/

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.